Cardiac Resynchronization Therapy May Be Antiarrhythmic Particularly in Responders

JACC: Clinical Electrophysiology - Tập 2 - Trang 307-316 - 2016
Aditya Saini1, Munish Kannabhiran1, Pratap Reddy1, Rakesh Gopinathannair2, Brian Olshansky3, Paari Dominic1
1Division of Cardiology, Department of Medicine, and Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center- Shreveport, Shreveport, Louisiana, USA
2Division of Cardiovascular Medicine, University of Louisville, Louisville, Kentucky, USA
3Cardiovascular Medicine, University of Iowa, Iowa City, Iowa, USA

Tài liệu tham khảo

Abraham, 2002, Cardiac resynchronization in chronic heart failure, N Engl J Med, 346, 1845, 10.1056/NEJMoa013168 Young, 2003, Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial, JAMA, 289, 2685, 10.1001/jama.289.20.2685 Linde, 2008, Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms, J Am Coll Cardiol, 52, 1834, 10.1016/j.jacc.2008.08.027 Cleland, 2005, The effect of cardiac resynchronization on morbidity and mortality in heart failure, N Engl J Med, 352, 1539, 10.1056/NEJMoa050496 Ouellet, 2012, Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT, J Am Coll Cardiol, 60, 1809, 10.1016/j.jacc.2012.05.057 Blaschke, 2012, Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators, Europace, 14, 224, 10.1093/europace/eur307 Higgins, 2003, Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 1454, 10.1016/S0735-1097(03)01042-8 Joep Thijssen, 2011, Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders, J Am Coll Cardiol, 58, 2282, 10.1016/j.jacc.2011.08.038 Medina-Ravell, 2003, Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?, Circulation, 107, 740, 10.1161/01.CIR.0000048126.07819.37 Shukla, 2005, Potential proarrhythmic effect of biventricular pacing: fact or myth?, Heart Rhythm, 2, 951, 10.1016/j.hrthm.2005.05.019 Di Biase, 2008, Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry, J Am Coll Cardiol, 52, 1442, 10.1016/j.jacc.2008.07.043 García-Lunar, 2014, Ventricular arrhythmias in super-responders to cardiac resynchronization therapy, Rev Esp Cardiol, 67, 883, 10.1016/j.recesp.2014.01.017 Markowitz, 2009, Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization, J Cardiovasc Electrophysiol, 20, 293, 10.1111/j.1540-8167.2008.01317.x van der Heijden, 2014, Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment, Eur J Heart Fail, 16, 1104, 10.1002/ejhf.152 Eickholt, 2012, Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia, PLoS One, 7, e48926, 10.1371/journal.pone.0048926 Friedman, 2014, Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy. Baseline predictors and associated clinical outcomes, Heart Rhythm, 11, 1991, 10.1016/j.hrthm.2014.08.005 Itoh, 2013, Time-dependent effect of cardiac resynchronization therapy on ventricular repolarization and ventricular arrhythmias, Europace, 15, 1798, 10.1093/europace/eut145 Timóteo, 2011, Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?, Rev Port Cardiol, 30, 823, 10.1016/j.repc.2011.09.004 Manfredi, 2013, Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias, Circ Arrhythm Electrophysiol, 6, 257, 10.1161/CIRCEP.112.000214 Ruwald, 2014, Circulation, 130, 2278, 10.1161/CIRCULATIONAHA.114.011283 Schaer, 2010, Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients, Eur J Heart Fail, 12, 1325, 10.1093/eurjhf/hfq171 Shahrzad, 2012, The effect of left ventricular (LV) remodeling on ventricular arrhythmia in cardiac resynchronization therapy (CRT-D) patients (antiarrhythmic effect of CRT), Pacing Clin Electrophysiol, 35, 592, 10.1111/j.1540-8159.2012.03345.x Van Boven, 2013, Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks, J Cardiovasc Electrophysiol, 24, 316, 10.1111/jce.12037 Gold, 2011, The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure, Heart Rhythm, 8, 679, 10.1016/j.hrthm.2010.12.031 Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting, JAMA, 283, 2008, 10.1001/jama.283.15.2008 Harris, 2001, Current methods of the US Preventive Services Task Force: a review of the process, Am J Prev Med, 20, 21, 10.1016/S0749-3797(01)00261-6 Levine, 1994, Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group, JAMA, 271, 1615, 10.1001/jama.1994.03510440075037 Gopinathannair, 2015, Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous flow left ventricular assist devices, J Cardiac Fail, 21, 226, 10.1016/j.cardfail.2014.12.006 Gopalamurugan, 2014, Is CRT pro-arrhythmic? A comparative analysis of the occurrence of ventricular arrhythmias between patients implanted with CRTs and ICDs, Front Physiol, 5, 334, 10.3389/fphys.2014.00334 Fish, 2005, Potential proarrhythmic effects of biventricular pacing, J Am Coll Cardiol, 46, 2340, 10.1016/j.jacc.2005.08.035 Zagrodzky, 2001, Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy, Am J Cardiol, 87, 1208, 10.1016/S0002-9149(01)01498-9 Haugaa, 2014, Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias, J Am Soc Echocardiogr, 27, 872, 10.1016/j.echo.2014.04.001 Nabeta, 2015, Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management, Heart Vessels Lin, 2008, Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices, Heart, 94, 186, 10.1136/hrt.2007.118372 Arya, 2005, Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator, Heart Rhythm, 2, 1094, 10.1016/j.hrthm.2005.07.007 Ermis, 2005, Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators, J Am Coll Cardiol, 46, 2258, 10.1016/j.jacc.2005.04.067 Voigt, 2005, Biventricular pacing reduces ventricular arrhythmic burden and defibrillator therapies in patients with heart failure, Clin Cardiol, 29, 74, 10.1002/clc.4960290208 Nordbeck, 2010, Effect of cardiac resynchronization therapy on the incidence of electrical storm, Int J Cardiol, 143, 330, 10.1016/j.ijcard.2009.03.055